Menu Back toSolution Circle: QPPV Perspective on Brexit - Is Your Pharmacovigilance System Compliant?

DIA 2021 Global Annual Meeting


Solution Circle: QPPV Perspective on Brexit - Is Your Pharmacovigilance System Compliant?

Session Chair(s)

  APCER Life Sciences

APCER Life Sciences

  • United States
Brexit has brought about changes in pharmacovigilance requirements for products authorized in the United Kingdom. Get a perspective from a qualified person for pharmacovigilance in the European Union (EU-QPPV) and the United Kingdom (UK-QPPV) on the guidance about new regulations, their impact on established pharmacovigilance systems and processes, impact of Brexit on pharma industry, major challenges related to MAH, QPPV and PV system in North Ireland and lessons learned by the Pharmaceuticals.

Speaker(s)

Frank  Laschewski, MD

Frank Laschewski, MD

  • QPPV
  • APCER Life Sciences, United Kingdom
Sameen  Wasif

Sameen Wasif

  • UK QPPV
  • APCER Life Sciences, United Kingdom
Kanwalpreet  Kaur

Kanwalpreet Kaur

  • QPPV & Senior Medical Safety Lead
  • APCER Life Sciences, United Kingdom